Certain confidential information contained in this document, marked by [**], has been omitted because ADC Therapeutics SA (ADCT) has determined that the information (i) is not material and (ii) would likely cause competitive harm to ADC Therapeutics...License Agreement • April 24th, 2020 • ADC Therapeutics SA • Pharmaceutical preparations
Contract Type FiledApril 24th, 2020 Company IndustryThis Second Amended and Restated License Agreement (“Agreement”) is made and entered into as of May 9, 2016 (“Execution Date”), by and among:
Certain confidential information contained in this document, marked by [**], has been omitted because ADC Therapeutics SA (ADCT) has determined that the information (i) is not material and (ii) would likely cause competitive harm to ADC Therapeutics...License Agreement • March 2nd, 2020 • ADC Therapeutics SA • Pharmaceutical preparations
Contract Type FiledMarch 2nd, 2020 Company IndustryThis Second Amended and Restated License Agreement (“Agreement”) is made and entered into as of May 9, 2016 (“Execution Date”), by and among:
Certain confidential information contained in this document, marked by [**], has been omitted because ADC Therapeutics SA (ADCT) has determined that the information (i) is not material and (ii) would likely cause competitive harm to ADC Therapeutics...License Agreement • September 6th, 2019 • ADC Therapeutics SA • Pharmaceutical preparations
Contract Type FiledSeptember 6th, 2019 Company IndustryThis Second Amended and Restated License Agreement (“Agreement”) is made and entered into as of May 9, 2016 (“Execution Date”), by and among: